Nucleozin,
341001-38-5,
[4-(2-chloro-4-nitrophenyl)piperazin-1-yl](5-methyl-3-phenyl-1,2-oxazol-4-yl)methanone,
[4-(2-chloro-4-nitrophenyl)piperazin-1-yl]-(5-methyl-3-phenyl-1,2-oxazol-4-yl)methanone,
AC1MF0BZ,
Oprea1_527445,
SCHEMBL1225006,
CHEMBL2032324,
DTXSID90386481,
BCP19971,
ZINC8781115,
3939AH,
STL262905,
AKOS016027347,
Nucleozin, >=98% (HPLC), powder,
CS-0099,
MCULE-6644356849,
NCGC00378806-01,
HY-50001,
ST030571,
W-5264,
SR-01000217909,
SR-01000217909-1,
(4-(2-Chloro-4-nitrophenyl)piperazin-1-yl)(5-methyl-3-phenylisoxazol-4-yl)methanone,
4-(2-chloro-4-nitrophenyl)piperazinyl 5-methyl-3-phenylisoxazol-4-yl ketone,
METHANONE, [4-(2-CHLORO-4-NITROPHENYL)-1-PIPERAZINYL](5-METHYL-3-PHENYL-4-ISOXAZOLYL)-,
NUZ,
C21H19ClN4O4,
D0G9FF,
Methanone,[4- -1-piperazinyl] -,
CID2863945,
A3670,
Influenza A nucleoprotein modulator, The Univeristy of Hong Kong,
[4-(2-chloro-4-nitro-phenyl)piperazin-1-yl]-(5-methyl-3-phenyl-1,2-oxazol-4-yl)methanone,
[4-(2-Chloro-4-nitrophenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)- methanone,
[4-(2-Chloro-4-nitrophenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)-methanone,